World
US Regulators Revoke Emergency Use of Malaria Drug for Coronavirus
Photo shows a box of Plaquenil, a brand of the antimalarial drug hydroxychloroquine made by Sanofi. / NURPHOTO / GETTY / KYODO
By Kyodo News 16 June 2020
WASHINGTON—US regulators on Monday revoked the emergency use of anti-malaria drug hydroxychloroquine, which US President Donald Trump previously said he was taking based on the belief that it would protect him against the novel coronavirus.
In late March, the US Food and Drug Administration granted the emergency use of the drug to treat patients hospitalized with the coronavirus when clinical trials were not available. But in late April, it warned that the drug’s side effects include “serious and potentially life-threatening heart rhythm problems.”
Read more.
